Dr. Elisabeth Lackner has been the CEO of ABF Pharmaceutical Services since 2010. Elisabeth graduated in pharmacy and holds a PhD and Master's degree in tumor biology. Her experience stems from having spent more than 15 years in the clinical research industry spanning basic research, sales, marketing, business development, global operations and project management roles. Prior to joining ABF, Elisabeth held a senior management role at Roche and was the Head of Manufacturing for five years. Having worked in different fields of clinical research for CROs, pharmaceutical and biotechnology companies she brings the perfect perspective to the supply chain and to the expertise of ABF.
Claudia Marker is the COO at ABF and joined the company in 2010. Claudia gained her project management and central laboratory experience at the "Austrian Agency for Health and Food Safety" (AGES). Having worked on the laboratory side of things, Claudia was responsible for establishing the central laboratory at ABF before being promoted to COO. Claudia holds an engineer's degree in biotechnology.
Matthias Hager has been Head of Production at ABF since 2013. Before that he worked in the field of clinical research as project manager and production assistant. Matthias has a Bachelor's and Master's degree in Natural Science and oversees the production process and is also in charge of the qualification of GMP-relevant machinery and validation of production-relevant processes.
Daniel Siderits is Head of Quality Assurance and Quality Control at ABF Pharmaceutical Services. Daniel graduated in biology and gained experience in quality and clinical research after having spent more than five years in research at university and in quality control.
Martin Schmuck joined ABF in 2015 as Head of Finance. Before joining ABF he held various senior positions in Finance & Controlling.